UTSW researchers neutralize genetic risk factor found in 50 to 80 percent of human cases
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Apolipoprotein E (ApoE) is a protein that carries fatty substances called lipids and cholesterol around the brain and plays an important role in repair mechanisms. There are three major forms of ApoE (i.e., ApoE2, ApoE3, and ApoE4); individuals who carry ApoE4 are up to 10 times more likely to develop Alzheimer’s than those with ApoE2 and ApoE3 forms. ApoE4 promotes accumulation of the b-amyloid protein that causes the characteristic plaques seen in the brains of Alzheimer’s patients.
UT Southwestern molecular biologist and Alzheimer’s expert Dr. Joachim Herz, lead author of the study, which was published in the November issue of eLife said the goal of his team is to prevent the disease from ever manifesting. Late-onset Alzheimer’s generally is diagnosed about age 65 and is the most common cause of dementia in the elderly. “If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer’s altogether for many people so that they will never get sick,” Dr. Herz said.
ApoE4 has been shown to suppress and trap synaptic receptors within intracellular vesicles. However, how the ApoE4 gets trapped has remained a mystery until now. According to Dr. Herz, ApoE4 is the root cause of a “traffic jam” inside the cells that take up ApoE4 and this is associated with reduced recycling of intracellular endosomal transport vesicles. UTSW researchers found that lowering the pH of these endosomes, i.e., by making them more acidic, cleared the traffic jam: The scientists were able to completely reverse the ApoE4-induced recycling block in mice through pharmacological and genetic inhibition of the NHE6 protein, which acts to make the endosomal vesicles less acidic.
These findings suggest a novel potential therapeutic approach for the prevention of late-onset Alzheimer’s disease, Dr. Herz said. The vesicle traffic jam due to the selective loss of solubility of ApoE4 likely is the earliest mechanism at which the protein negatively affects nerve cells, Dr. Herz said.
Most Alzheimer’s research has focused on halting the formation of amyloid and tau protein aggregates once they exist in the brain and degeneration has already begun. “Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates,” Dr. Herz said.
The next step is to develop tailor-made, small molecule inhibitors that can enter the brain efficiently and selectively block NHE6, he added.
“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.
The Latest on: Late-onset Alzheimer’s
via Google News
The Latest on: Late-onset Alzheimer’s
- Tests for Alzheimer’s disease show promiseon August 12, 2020 at 7:13 pm
He notes that both methods seem to work long before symptoms appear in early-onset Alzheimer’s, but says it remains to be seen if they can detect the more common late-onset disease.
- Plasma Cholesterol and Risk for Late-onset Alzheimer's Diseaseon August 5, 2020 at 5:00 pm
An apparent contradictory observation in the study is that not only low HDL-C, but also low non-HDL-C levels, are associated with higher AD risk. It could be expected that high non-HDL-C would ...
- Charity warns of an 'alarming' drop in number of over-65s getting diagnosed with dementia and says 'another hidden crisis is growing'on August 5, 2020 at 8:29 am
NHS data shows almost 30,000 fewer over-65s in England thought to have Alzheimer's disease were listed as being a sufferer in June compared to February.
- Education may be protective for people with gene for familial early onset Alzheimer'son August 4, 2020 at 5:00 pm
Aug. 17, 2016 — Scientists reveal why people with the ApoE4 gene are more susceptible to Alzheimer's disease. Late-onset Alzheimer's disease--the subset of the disorder occurring in people age ...
- A quantitative trait rare variant nonparametric linkage method with application to age-at-onset of Alzheimer’s diseaseon August 1, 2020 at 2:38 am
RV-QNPL was also applied to analyze age-at-onset (AAO) data for 107 late-onset Alzheimer’s disease (LOAD) pedigrees of Caribbean Hispanic and European ancestry with whole-genome sequence data.
- A blood test for Alzheimer's that's almost 100% accurateon July 27, 2020 at 5:00 pm
It is unknown what causes Alzheimer's. Those who have the APOE gene are more likely to develop late-onset Alzheimer's. Signs and symptoms: Stages of Alzheimer's: Dr Amanda Heslegrave ...
- Pneumonia vaccine may cut Alzheimer's risk by up to 40%on July 27, 2020 at 12:29 pm
A new study from Duke University found that receiving the pneumonia vaccine reduces the risk of developing Alzheimer's by 25% to 30% and up to 40% in those without genetic risk factors.
- Plasma Cholesterol and Risk for Late-onset Alzheimer's Diseaseon July 25, 2020 at 5:00 pm
Alzheimer's disease (AD), the most common cause of dementia, is a progressive neurodegenerative disorder affecting millions of people worldwide. AD has a multifactorial origin, resulting from an ...
- Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal agingon July 23, 2020 at 5:00 pm
Although APOE ɛ4 and genetic scores for late-onset Alzheimer’s disease (LOAD) have been related to cognitive decline during preclinical stages of dementia, there is limited knowledge concerning ...
- Families hit by rare early Alzheimer’s pushing for researchon July 19, 2020 at 5:00 pm
On Sunday, researchers at the Alzheimer’s Association International Conference reported possible new ways to predict who will get sick with the more common late-onset Alzheimer’s – vital to ...
via Bing News